Adrian Harel, Ph.D.

Turku Area, Finland Finland

CEO & Founder at Medicortex Finland Oy ►Traumatic Brain Injury (TBI) ► Concussion ► Head Trauma

Medical / Health Care / Pharmaceuticals

► “He combines a broad scientific education with extensive industry experience. He holds a Ph.D. in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University. Dr. Harel has many years of experience in the pharmaceutical and biotech industry. Dr. Harel has extensive Drug research & development know-how and GMP production and manufacturing knowledge” ► MediCortex is dedicated to drug discovery for acute neurodegenerative conditions such as traumatic brain injury (TBI), stroke and others. The company's initial focus is on preventing secondary brain injury in TBI, a complex process caused by a multitude of biochemical changes. MediCortex's unique n...